{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:55:28Z","timestamp":1789167328641,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"BMBF Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102411","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:26:19Z","timestamp":1760556379000},"page":"102411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimized arenaviruses with tumor-tropic mutations promote safe anti-tumor efficacy via sustainable immune modulatory properties"],"prefix":"10.1016","volume":"6","author":[{"given":"Philipp A.","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Holnsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara M.","family":"Machlah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Kim","family":"Friedrich-Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bergerhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Z\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Keizers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Gorzkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshia","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Jelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dethardt","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Kostka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng C.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl S.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102411_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050939","article-title":"Oncolytic Virotherapy: The Cancer Cell Side","volume":"13","author":"Ehrlich","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2025.102411_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-019-0029-0","article-title":"Optimizing oncolytic virotherapy in cancer treatment","volume":"18","author":"Harrington","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102411_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14447","article-title":"Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression","volume":"8","author":"Kalkavan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102411_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3389\/fimmu.2020.01849","article-title":"Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression","volume":"11","author":"Bhat","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102411_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm1780","article-title":"Aggravation of viral hepatitis by platelet-derived serotonin","volume":"14","author":"Lang","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102411_bib6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1670","article-title":"Extralymphatic virus sanctuaries as a consequence of potent T-cell activation","volume":"13","author":"Recher","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102411_bib7","series-title":"Fields Virology: Emerging Viruses","volume":"7","author":"Howley","year":"2020"},{"key":"10.1016\/j.xcrm.2025.102411_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301885","article-title":"ICP34. 5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties","volume":"10","author":"Liu","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2025.102411_bib9","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102411_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102411_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5662\/wjm.v6.i1.25","article-title":"Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity","volume":"6","author":"Gong","year":"2016","journal-title":"World J. Methodol."},{"key":"10.1016\/j.xcrm.2025.102411_bib12","doi-asserted-by":"crossref","first-page":"E4504","DOI":"10.1073\/pnas.1408759111","article-title":"Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers","volume":"111","author":"Lin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102411_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ymthe.2004.12.012","article-title":"Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule","volume":"11","author":"Nakano","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102411_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007209","article-title":"A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors","volume":"14","author":"Leoni","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.102411_bib15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102411_bib16","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/JVI.76.10.5140-5146.2002","article-title":"New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor","volume":"76","author":"Spiropoulou","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115196","article-title":"The role of glycosylation patterns of viral glycoproteins and cell entry receptors in arenavirus infection","volume":"166","author":"Gorzkiewicz","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2025.102411_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003232","article-title":"TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine","volume":"9","author":"Jemielity","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.102411_bib19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1292\/jvms.12-0176","article-title":"Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein","volume":"74","author":"Shimojima","year":"2012","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.xcrm.2025.102411_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/pathogens8010017","article-title":"Virus\u2013host interactions involved in Lassa virus entry and genome replication","volume":"8","author":"Loureiro","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.xcrm.2025.102411_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009996","article-title":"Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants","volume":"17","author":"Volland","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.102411_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119676119","article-title":"CD164 is a host factor for lymphocytic choriomeningitis virus entry","volume":"119","author":"Bakkers","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102411_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-12-809633-8.20958-8","article-title":"Genetic diversity and evolution of viral populations","volume":"1","author":"Sanjuan","year":"2021","journal-title":"Encyclopedia of Virology"},{"key":"10.1016\/j.xcrm.2025.102411_bib24","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1073\/pnas.0408871102","article-title":"Suppression of viral infectivity through lethal defection","volume":"102","author":"Grande-Perez","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102411_bib25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4049\/jimmunol.2300637","article-title":"High-Affinity-Mediated Viral Entry Triggers Innate Affinity Escape Resulting in Type I IFN Resistance and Impaired T Cell Immunity","volume":"212","author":"Xu","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102411_bib73","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s42003-021-02028-x","article-title":"Slow viral propagation during initial phase of infection leads to viral persistence in mice","volume":"4","author":"Xu","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.xcrm.2025.102411_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nsmb.3210","article-title":"Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV","volume":"23","author":"Hastie","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102411_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053273","article-title":"LCMV glycosylation modulates viral fitness and cell tropism","volume":"8","author":"Bonhomme","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102411_bib28","doi-asserted-by":"crossref","first-page":"E7814","DOI":"10.1073\/pnas.1804674115","article-title":"Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics","volume":"115","author":"Oldstone","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102411_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003073","article-title":"Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease","volume":"8","author":"Schnell","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.102411_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature13902","article-title":"In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR\/Cas9 system","volume":"516","author":"Maddalo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102411_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jmv.2206","article-title":"Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus","volume":"67","author":"Lukashevich","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib32","first-page":"71","article-title":"Experimental inhalation infection of monkeys of the macacus cynomolgus and macacus rhesus species with the virus of lymphocytic choriomeningitis (WE)","volume":"2","author":"Danes","year":"1963","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.xcrm.2025.102411_bib33","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41467-021-21389-9","article-title":"Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19","volume":"12","author":"Salguero","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102411_bib34","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1099\/vir.0.82804-0","article-title":"Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses","volume":"88","author":"El Mubarak","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-8-205","article-title":"Pathogenesis of Lassa fever in cynomolgus macaques","volume":"8","author":"Hensley","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.xcrm.2025.102411_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coviro.2019.07.005","article-title":"Animal models for Lassa virus infection","volume":"37","author":"Tang-Huau","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib37","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-13-0094","article-title":"Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1","volume":"74","author":"Schadler","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102411_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01219-17","article-title":"IRF9 Prevents CD8(+) T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection","volume":"91","author":"Huber","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003650","article-title":"Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes","volume":"9","author":"Honke","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.102411_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.23640","article-title":"Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice","volume":"52","author":"Lang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2025.102411_bib41","first-page":"726","article-title":"Arenavirus Therapy in Combination with Checkpoint Blockade as an Effective Way for Better Tumour Clearance","volume":"55","author":"Bhat","year":"2021","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.xcrm.2025.102411_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2008","article-title":"Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses","volume":"28","author":"Matveeva","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.75.1.448-457.2001","article-title":"Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor \u03b1-dystroglycan correlate with viral tropism and disease kinetics","volume":"75","author":"Smelt","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/jvi.69.2.1059-1070.1995","article-title":"Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression","volume":"69","author":"Borrow","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib45","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.192.9.1249","article-title":"Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells","volume":"192","author":"Sevilla","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102411_bib46","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1073\/pnas.1907070116","article-title":"A unique variant of lymphocytic choriomeningitis virus that induces pheromone binding protein MUP: Critical role for CTL","volume":"116","author":"Ware","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102411_bib47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.virol.2004.05.009","article-title":"Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus","volume":"325","author":"Kunz","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2025.102411_bib48","doi-asserted-by":"crossref","first-page":"21641","DOI":"10.1073\/pnas.1011998107","article-title":"Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression","volume":"107","author":"Bergthaler","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102411_bib49","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/jvi.68.11.7367-7373.1994","article-title":"Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence","volume":"68","author":"Evans","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib50","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1073\/pnas.1019304108","article-title":"Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence","volume":"108","author":"Sullivan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102411_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-023-02726-w","article-title":"AXL in cancer: a modulator of drug resistance and therapeutic target","volume":"42","author":"Tang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102411_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1476-4598-12-115","article-title":"CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1\u03b1\/CXCR4 axis","volume":"12","author":"Huang","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102411_bib53","doi-asserted-by":"crossref","first-page":"54115","DOI":"10.18632\/oncotarget.11132","article-title":"CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt\/mTOR signaling","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2025.102411_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00205-22","article-title":"Genome-Wide Knockout Screen Identifies Human Sialomucin CD164 as an Essential Entry Factor for Lymphocytic Choriomeningitis Virus","volume":"13","author":"Liu","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2025.102411_bib55","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/ijc.30397","article-title":"Heparan sulfate proteoglycans mediate renal carcinoma metastasis","volume":"139","author":"Qazi","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102411_bib56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12885-018-4597-x","article-title":"Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character","volume":"18","author":"Crespo","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.102411_bib57","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.antiviral.2010.09.002","article-title":"Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein","volume":"88","author":"Kato","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.xcrm.2025.102411_bib58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41421-020-00222-5","article-title":"Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro","volume":"6","author":"Zhang","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2025.102411_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.200104103","article-title":"Molecular analysis of the interaction of LCMV with its cellular receptor \u03b1-dystroglycan","volume":"155","author":"Kunz","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102411_bib60","doi-asserted-by":"crossref","first-page":"14297","DOI":"10.1128\/JVI.79.22.14297-14308.2005","article-title":"O mannosylation of \u03b1-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function","volume":"79","author":"Imperiali","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12935-022-02812-7","article-title":"Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis","volume":"22","author":"Quereda","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.xcrm.2025.102411_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.spen.2012.02.002","article-title":"Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult","volume":"19","author":"Bonthius","year":"2012","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.xcrm.2025.102411_bib64","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1159\/000443067","article-title":"IL-10 Induces T Cell Exhaustion During Transplantation of Virus Infected Hearts","volume":"38","author":"Gassa","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.xcrm.2025.102411_bib62","first-page":"157","article-title":"The treatment of 18 cases of malignant disease with an arenavirus","volume":"1","author":"Webb","year":"1975","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102411_bib63","first-page":"1066","article-title":"The effects of MP virus infection in lymphoma","volume":"31","author":"Horton","year":"1971","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102411_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/tropicalmed6020088","article-title":"Lymphocytic Choriomeningitis-Emerging Trends of a Neglected Virus: A Narrative Review","volume":"6","author":"Vilibic-Cavlek","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.102411_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.057000-0","article-title":"Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections","volume":"95","author":"McLay","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.xcrm.2025.102411_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed6020088","article-title":"Lymphocytic Choriomeningitis-Emerging Trends of a Neglected Virus: A Narrative Review","volume":"6","author":"Vilibic-Cavlek","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.102411_bib68","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41467-019-11137-5","article-title":"Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy","volume":"10","author":"Niemann","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102411_bib69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.omtm.2020.01.001","article-title":"Oncolytic viruses and the immune system: the dynamic duo","volume":"17","author":"De Matos","year":"2020","journal-title":"Mol Ther Methods Clin Dev."},{"key":"10.1016\/j.xcrm.2025.102411_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/erv.12.139","article-title":"The search for animal models for Lassa fever vaccine development","volume":"12","author":"Lukashevich","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.xcrm.2025.102411_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:14:33Z","timestamp":1788563673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004847"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102411","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized arenaviruses with tumor-tropic mutations promote safe anti-tumor efficacy via sustainable immune modulatory properties","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102411"}}